SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-20-002095
Filing Date
2020-08-13
Accepted
2020-08-13 17:16:47
Documents
55
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q embi_10q.htm 10-Q 476189
2 EX-31.1 embi_ex311.htm EX-31.1 8629
3 EX-31.2 embi_ex312.htm EX-31.2 8568
4 EX-32.1 embi_ex321.htm EX-32.1 3460
5 EX-32.2 embi_ex322.htm EX-32.2 3428
  Complete submission text file 0001640334-20-002095.txt   4268318

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT embi-20200630.xml EX-101.INS 710619
7 XBRL TAXONOMY EXTENSION SCHEMA embi-20200630.xsd EX-101.SCH 70681
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE embi-20200630_cal.xml EX-101.CAL 25944
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE embi-20200630_def.xml EX-101.DEF 217037
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE embi-20200630_lab.xml EX-101.LAB 723151
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE embi-20200630_pre.xml EX-101.PRE 319253
Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121 (949) 480-9051
Emerald Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 201100259
SIC: 2834 Pharmaceutical Preparations